MedTrace Logo

Assessing the Impact of the Axomove Therapy Medical Device on Low Back Pain Patients

NCT05910463 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2023-07-21

No results posted yet for this study

Summary

An evaluation study of the impact of the Axomove Therapy® medical device on subacute or chronic low back pain patients leaving rehabilitation centres to facilitate self-rehabilitation. A prospective, randomized, open-label, multicentre study whose main objective is to evaluate the effectiveness of the Axomove Therapy Medical Device on disability reduction (Oswestry disability index score) patients with subacute or chronic low back pain requiring rehabilitation.

Conditions

  • Low Back Pain

Interventions

OTHER

AXOMOVE Therapy Medical Device

Personalized exercise programs for the self-rehabilitation of low back pain patients

Sponsors & Collaborators

  • Axomove

    lead INDUSTRY

Principal Investigators

  • Valerie WIECZOREK, MD · CHU de Lille

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910463 on ClinicalTrials.gov